Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Novartis Bioventures Ltd. investment portfolio
Novartis Bioventures Ltd. has made numerous investments in companies such as Amphista Therapeutics, Astronautx, and Artios Pharma within the Biotech sector.
unknown
Portfolio
4
Team
0
Portfolio (4)
| Company | Sector | Source | Last confirmed on |
|---|---|---|---|
| Amphista Therapeutics Limited AMPHISTA THERAPEUTICS LIMITED is a biopharmaceutical company that develops next-generation targeted protein degradation (TPD) therapeutics. They utilize their proprietary Targeted Glue® technology to selectively degrade and remove disease-causing proteins. Their focus is on developing treatments for a range of severe diseases, including oncology, neurodegenerative diseases, immunology, and inflammatory disorders. | Healthcare & Life Sciences | Confirmed | 2025-12-06 |
| Artios Pharma Limited | Healthcare & Life Sciences | Confirmed | 2025-12-28 |
Shareholding changes (5)
Novartis Bioventures Ltd.'s positions across portfolio companies2025
- SERIES D SHARES 0 → 6,585,541
- SERIES D1 SHARES 0 → 1,242,723
- SERIES B PREFERRED 982,456 → 1,333,333
Articles (1)
- Loqus23 Therapeutics secures £15m funding for neurodegenerative disease research3 Jun 2026Loqus23 Therapeutics